The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells
Open accessAbstract
The family of ubiquitin (Ub)-specific proteases (USP) removes Ub from Ub conjugates and regulates a variety of cellular processes. The human genome contains many putative USP-encoding genes, but little is known about USP tissue distribution, pattern of expression, activity, and substrate specificity. We have used a chemistry-based functional proteomics approach to identify active USPs in normal, virus-infected, and tumor-derived human cells. Depending on tissue origin and stage of activation/differentiation, different USP activity profiles were revealed. The activity of specific USPs, including USP5, -7, -9, -13, -15, and -22, was up-regulated by mitogen activation or virus infection in normal T and B lymphocytes. UCH-L1 was highly expressed in tumor cell lines of epithelial and hematopoietic cell origin but was not detected in freshly isolated and mitogen-activated cells. Up-regulation of this USP was a late event in the establishment of Epstein–Barr virus-immortalized lymphoblastoid cell lines and correlated with enhanced proliferation, suggesting a possible role in growth transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unique DUB activity was additionally identified following EBV establishment of latency and correlated with changes in cell proliferation rates.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [145]
In the citing paper
“By using AP of active DUBs and MS analysis, the activities of several DUBs were found to be strongly upregulated in EBV-infected lymphocytes (145).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,296
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. J. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,048
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,018
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 964
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 947
The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal Hydrolase
Wilkinson, K. D., Lee, K., Deshpande, S. S., Duerksen-Hughes, P. J., Boss, J. M., & Pohl, J. (1989) · Science · doi:10.1126/science.2530630 · Cited by 871
Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., & Lansbury, P. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01012-7 · Cited by 786
A cryptic protease couples deubiquitination and degradation by the proteasome
Yao, T., & Cohen, R. E. (2002) · Nature · doi:10.1038/nature01071 · Cited by 727
Jensen, D. E., Proctor, M. L., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 725
Chemistry-Based Functional Proteomics Reveals Novel Members of the Deubiquitinating Enzyme Family
Borodovsky, A., Ovaa, H., Kolli, N., Gan-Erdene, T., Wilkinson, K. D., Ploegh, H. L., & Kessler, B. M. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00248-x · Cited by 588
Self-citation
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Research works printed but not linked: 10
- Gray, D. A., Inazawa, J., Gupta, K., Wong, A., Ueda, R. & Takahashi, T. (1995) Oncogene 10, 2179–2183.7784062
- D'Andrea, V., Malinovsky, L., Berni, A., Biancari, F., Biassoni, L., Di Matteo, F. M., Corbellini, L., Falvo, L., Santoni, F., Spyrou, M. & De Antoni, E. (1997) G Chir 18, 521–524.9435142
- Tezel, E., Hibi, K., Nagasaka, T. & Nakao, A. (2000) Clin. Cancer Res. 6, 4764–4767.11156232
- Brichory, F., Beer, D., Le Naour, F., Giordano, T. & Hanash, S. (2001) Cancer Res. 61, 7908–7912.11691811
- Kieff, E. (1996) in Fields Virology, eds. Fields, B. N., Knipe, D. M. & Howley, P. M. (Lippincott, Raven, Philadelphia), Vol. 2, 3rd Ed., pp. 2343–2396.
- Finch, J. S., St. John, T., Krieg, P., Bonham, K., Smith, H. T., Fried, V. A. & Bowden, G. T. (1992) Cell Growth Differ. 3, 269–278.1321656
- Fischer-Vize, J. A., Rubin, G. M. & Lehmann, R. (1992) Development (Cambridge, U.K.) 116, 985–1000.
- Scheper, R. J., Broxterman, H. J., Scheffer, G. L., Kaaijk, P., Dalton, W. S., van Heijningen, T. H., van Kalken, C. K., Slovak, M. L., de Vries, E. G., van der Valk, P., et al. (1993) Cancer Res. 53, 1475–1479.7680954
- Filipits, M., Jaeger, U., Simonitsch, I., Chizzali-Bonfadin, C., Heinzl, H. & Pirker, R. (2000) Clin. Cancer Res. 6, 3417–3423.10999723
- Filipits, M., Drach, J., Pohl, G., Schuster, J., Stranzl, T., Ackermann, J., Konigsberg, R., Kaufmann, H., Gisslinger, H., Huber, H., et al. (1999) Clin. Cancer Res. 5, 2426–2430.10499614
Cited by
Sorted by citations
Items 101–193 of 193
Li, Z., Baccianti, F., Delécluse, S., Tsai, M., Shumilov, A., Cheng, X., Ma, S., Hoffmann, I., Poirey, R., & Delecluse, H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115508118 · Cited by 29
Chemistry-based functional proteomics for drug target deconvolution
Wang, K., Yang, T., Wu, Q., Zhao, X., Nice, E. C., & Huang, C. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.19 · Cited by 29
The ubiquitin C‐terminal hydrolase UCH‐L1 regulates B‐cell proliferation and integrin activation
Rolén, U., Freda, E., Xie, J., Pfirrmann, T., Frisan, T., & Masucci, M. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00501.x · Cited by 29
Self-citationBoutell, C., Everett, R. D., Hilliard, J. G., Schaffer, P. A., Orr, A., & Davido, D. J. (2008) · Journal of Virology · doi:10.1128/jvi.01063-08 · Cited by 28
Bassères, E., Coppotelli, G., Pfirrmann, T., Andersen, J. B., Masucci, M. G., & Frisan, T. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01495.x · Cited by 27
Self-citationMultifarious proteomic signatures and regional heterogeneity in glioblastomas
Park, C., Jung, J. H., Park, S., Jung, H., & Cho, B.-K. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9805-8 · Cited by 25
Shahab Uddin, M. S., Hussain, A. R., Ahmed, M., Belgaumi, A., Al‐Dayel, F., Ajarim, D. S., Bavi, P. P., & Al-Kuraya, K. S. (2008) · The Journal of Pathology · doi:10.1002/path.2433 · Cited by 25
Biological functions of hyaluronan and cytokine-inducible deubiquitinating enzymes
Ramakrishna, S., Suresh, B., & Baek, K. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.11.006 · Cited by 24
Shahab Uddin, M. S., Ahmed, M., Hussain, A. R., Jehan, Z., Al‐Dayel, F., Munkarah, A. R., Bavi, P. P., & Al-Kuraya, K. S. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.75 · Cited by 22
Dalmas, D. A., Scicchitano, M. S., Chen, Y., Kane, J., Mirabile, R. C., Schwartz, L. W., Thomas, H. C., & Boyce, R. W. (2008) · Toxicologic Pathology · doi:10.1177/0192623307311400 · Cited by 22
KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation
Bentz, G. L., Bheda-Malge, A., Wang, L., Shackelford, J., Damania, B., & Pagano, J. S. (2013) · Virology · doi:10.1016/j.virol.2013.10.018 · Cited by 20
Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast
Gatti, L., Hoe, K., Hayles, J., Righetti, S. C., Carenini, N., Bo, L. D., Kim, D. U., Park, H. O., & Perego, P. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-44 · Cited by 20
Zhao, H., Adler, K. B., Bai, C., Tang, F., & Wang, X. (2006) · Journal of Proteome Research · doi:10.1021/pr050389v · Cited by 20
Yang, J. C., Weisberg, E., Qi, S., Wei Min, N. I., Mei, H., Wang, Z., Meng, C., Zhang, S., Hou, M., Qi, Z., et al. (2022) · Leukemia · doi:10.1038/s41375-021-01494-w · Cited by 19
The Promise of Proteomics in the Study of Oncogenic Viruses
McBride, A. A. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o116.065201 · Cited by 19
Discovery of Small Molecule Antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain
Mann, M. K., Franzoni, I., de Freitas, R. F., Tempel, W., Houliston, S., Smith, L., Vedadi, M., Arrowsmith, C. H., Harding, R., & Schapira, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00988 · Cited by 17
PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells
Bheda, A., Yue, W., Gullapalli, A., Shackelford, J., & Pagano, J. S. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.562571 · Cited by 18
Cloning and Characterization of the Human USP22 Gene Promoter
Xiong, J., Che, X., Li, X., Yu, H., Gong, Z., & Li, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052716 · Cited by 18
Carminati, P. O., Mello, S. S., Fachin, A. L., Junta, C. M., Sandrin‐Garcia, P., Carlotti, C. G., Donadi, E. A., Passos, G. A. S., & Sakamoto‐Hojo, E. T. (2010) · Genetics and Molecular Biology · doi:10.1590/s1415-47572010005000013 · Cited by 17
Dysregulated expression of SKP2 and its role in hematological malignancies
Kuliński, M., Achkar, I. W., Haris, M., Dermime, S., Mohammad, R. M., & Shahab Uddin, M. S. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1359740 · Cited by 17
ABPP and Host–Virus Interactions
Desrochers, G. F., & Pezacki, J. P. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_139 · Cited by 17
Proteasomal Serine Hydrolases Are Up-Regulated by and Required for Influenza Virus Infection
Shahiduzzaman, M., Ezatti, P., Xin, G., & Coombs, K. M. (2014) · Journal of Proteome Research · doi:10.1021/pr5001779 · Cited by 16
The Role of Coinfections in the EBV–Host Broken Equilibrium
Sánchez-Ponce, Y., & Fuentes‐Pananá, E. M. (2021) · Viruses · doi:10.3390/v13071399 · Cited by 16
A Novel RNAi Lethality Rescue Screen to Identify Regulators of Adipogenesis
van Beekum, O., Gao, Y., Berger, R., Koppen, A., & Kalkhoven, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037680 · Cited by 16
Kessler, B. M. (2006) · Expert Review of Proteomics · doi:10.1586/14789450.3.2.213 · Cited by 16
Self-citationThe Central Role of the Ubiquitin–Proteasome System in EBV-Mediated Oncogenesis
Pei, Y., & Robertson, E. S. (2022) · Cancers · doi:10.3390/cancers14030611 · Cited by 15
A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present)
Li, P., Liu, Y., & Liu, H.-M. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2058873 · Cited by 16
Siegel, D. S. D. (2012) · Seminars in Hematology · doi:10.1053/j.seminhematol.2012.05.005 · Cited by 15
Biotransformation of Chinese Herbs and Their Ingredients
Bai-ping, M., Feng, B., Hongzhi, H., & Yuwen, C. (2010) · World Science and Technology · doi:10.1016/s1876-3553(11)60012-4 · Cited by 15
Galardy, P. J., Ploegh, H. L., & Ovaa, H. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)99008-3 · Cited by 15
Self-citationMolecular piracy: manipulation of the ubiquitin system by Kaposi's sarcoma‐associated herpesvirus
Fujimuro, M., Hayward, S. D., & Yokosawa, H. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.549 · Cited by 14
Kapadia, B. B., & Gartenhaus, R. B. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0307 · Cited by 14
Integrative oncoproteomics strategies for anticancer drug discovery
Liu, R., Wang, K., Yuan, K., Wei, Y., & Huang, C. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.14 · Cited by 13
Wang, Q., Zhang, Q., Zheng, M., Wen, J., Li, Q., & Zhao, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.590679 · Cited by 13
Strategies for detection and quantification of cysteine cathepsins-evolution from bench to bedside
Hughes, C. S., Burden, R. E., Gilmore, B., & Scott, C. J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.07.029 · Cited by 13
Jia, P., Zhang, W., Xiang, Y., Lu, X., Liu, W., Jia, K., & Yi, M. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.04.065 · Cited by 12
Current Approaches on Viral Infection: Proteomics and Functional Validations
Zheng, J., Tan, B. H., Sugrue, R. J., & Tang, K. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00393 · Cited by 11
Noel, E. A., Kang, M., Adamec, J., Etten, J. L. V., & Oyler, G. A. (2014) · Journal of Virology · doi:10.1128/jvi.02109-14 · Cited by 12
Chen, B., Ge, S.-S., Zhao, Y., Chen, C., & Yang, S. (2016) · RSC Advances · doi:10.1039/c6ra20006k · Cited by 11
Imhoff, R. D., Rosenthal, M. R., Ashraf, K., Bhanot, P., Ng, C. L., & Flaherty, D. P. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129458 · Cited by 10
p38 mitogen-activated protein kinase inhibits USP22 transcription in HeLa cells
Xiong, J., Gong, Z., Zhou, X., Liu, J., He, J., Wu, P., & Li, W. (2015) · Biomedical Reports · doi:10.3892/br.2015.450 · Cited by 10
Kim, S. J., Lee, S. Y., Lee, C. M., Kim, I., An, H. J., Kim, J. Y., Baek, K., Kim, E. J., Kim, J. M., Lee, J. B., et al. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.015 · Cited by 10
Gkiafi, Z., & Panayotou, G. (2011) · Journal of Proteome Research · doi:10.1021/pr100793m · Cited by 10
Xiong, J., Xu, X., Zhou, X., LIU, J., Gong, Z., Wu, P., & Li, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2666 · Cited by 10
Dou, Y., Lin, J.-P., Shu, H., & Jiang, N. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2589 · Cited by 10
KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle
Chappell, D. L., Sandhu, P., Wong, J. P., Bhatt, A. P., Liu, X., Buhrlage, S. J., Temple, B. R. S., Major, M. B., & Damania, B. (2023) · Journal of Virology · doi:10.1128/jvi.01763-22 · Cited by 8
Zheng, Y., Shi, D., Chen, L., Yang, Y., & Yao, M. (2023) · Aging · doi:10.18632/aging.205097 · Cited by 8
A pathological missense mutation in the deubiquitinase USP5 leads to insensitivity to pain
Antunes, F. T. T., Gandini, M. A., Garcı́a-Caballero, A., Huang, S., Ali, M. Y., Gambeta, E., Souza, I. A., Harding, E. K., Ferron, L., Stray‐Pedersen, A., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241877 · Cited by 8
Harrigan, J. A., & Jacq, X. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3756-1_26 · Cited by 7
Pirarubicin reduces USP22 expression by inhibiting CREB‑1 phosphorylation in HeLa cells
Zhou, X., Gan, L., Liu, J., Xie, X., Wang, T., & Xiong, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7447 · Cited by 7
RUNX1 regulates MCM2/CDC20 to promote COAD progression modified by deubiquitination of USP31
Tian, W., Zhao, J., Zhang, X., Li, P., Li, X., Yuan, H., & Li, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-64726-w · Cited by 6
Kumar, A., Francis, M., Bhaskar, S., Vishnuvajhala, S., & Prasanna, J. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203723666220422092023 · Cited by 6
Is there an alternative to the proteasome in cytosolic protein degradation?
Antón, L. C., & Villasevil, E. M. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360839 · Cited by 6
Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene
Bedekovics, T., Hussain, S., & Galardy, P. J. (2019) · Oncotarget · doi:10.18632/oncotarget.27154 · Cited by 6
Self-citationIdentification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia
Guven‐Maiorov, E., Keskin, Ö., Ng, Ö. H., Özbek, U., & Gürsoy, A. (2013) · BioMed Research International · doi:10.1155/2013/210253 · Cited by 5
RANBP2 and USP9x regulate nuclear import of adenovirus minor coat protein IIIa
Ismail, A. M., Saha, A., Lee, J. S., Painter, D. F., Chen, Y., Singh, G., Condezo, G. N., Chodosh, J., Martín, C. S., & Rajaiya, J. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010588 · Cited by 5
Zheng, H., Wang, M., Zhao, C., Wu, S., Yu, P., Lü, Y., Wang, T., & Ai, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186535 · Cited by 5
Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Griffin, P. Y., Sexton, A., MacNeill, L., Iizuka, Y., Lee, M. K., & Bazzaro, M. (2015) · Journal of Visualized Experiments · doi:10.3791/52784 · Cited by 5
Targeting the Ubiquitin Proteasome System in Cancer
Kumari, N., Lee, K. K., & Jha, S. (2018) · InTech eBooks · doi:10.5772/intechopen.76705 · Cited by 5
Sample Preparation of Body Fluids for Proteomics Analysis
Govorukhina, N. I., & Bischoff, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-432-2_2 · Cited by 4
Activity-Based Imaging and Biochemical Profiling Tools for Analysis of the Cancer Degradome
Dive, V., Paulick, M. G., McIntyre, J. O., Matrisian, L. M., & Bogyo, M. S. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5_7 · Cited by 4
Molecular diagnosis of parathyroid carcinoma: a reality in the near future
Falchetti, A., Cavalli, L., Cavalli, T., Giusti, F., Marcucci, G., Marini, F., & Brandi, M. L. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2012.634796 · Cited by 4
Biotransformation of Chinese Herbs and Their Ingredients
Rongcai, Y., Lei, S., Shikai, Y., Zhao, J., & Zhang, W. (2010) · World Science and Technology · doi:10.1016/s1876-3553(11)60019-7 · Cited by 3
Omics-Level Approaches to Studying Gammaherpesvirus Infection
Hisam, F., Konakalla, A. R., Berisha, E., Castro, M. D. C. C., Mukherjee, S., Wang, C., Sheirbon, B. R., Delgado, T., & Sanchez, E. L. (2026) · Pathogens · doi:10.3390/pathogens15070713 · Cited by 2
Mukhtar, M. U., Iqbal, N., Yang, J., Niu, Q., Zhao, S., Li, Z., Zhao, Y., Rashid, I., Chen, Z., Guan, G., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-3975-9 · Cited by 2
The Deubiquitylase USP5 Knockdown Reduces Semliki Forest Virus Replication in HeLa Cells
Nubgan, A. (2022) · Maǧallaẗ ǧāmiʿaẗ al-Sulṭān Qābūs li-l-ʿulūm/Sultan Qaboos University journal for science · doi:10.53539/squjs.vol26iss2pp76-85 · Cited by 2
Activity Based Profiling of Deubiquitylating Enzymes and Inhibitors in Animal Tissues
McLellan, L., Forder, C., Cranston, A. N., Harrigan, J. A., & Jacq, X. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3756-1_27 · Cited by 2
Chemical Synthesis of Activity-Based Diubiquitin Probes
Li, G., Yuan, L., & Zhuang, Z. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6539-7_16 · Cited by 2
Targeting Proteasomal Degradation of Soluble, Misfolded Proteins
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801944-3.00003-5 · Cited by 2
Cracking the Ubiquitin Code: the Ubiquitin Toolbox
Mulder, M. P. C., Witting, K. F., & Ovaa, H. (2019) · Caister Academic Press eBooks · doi:10.21775/9781912530120.02 · Cited by 2
Self-citationDissecting Intracellular Proteolysis Using Small Molecule Inhibitors and Molecular Probes
Ovaa, H., Overkleeft, H. S., Kessler, B. M., & Ploegh, H. L. (2005) · Wiley eBooks · doi:10.1002/9783527620210.ch3 · Cited by 2
Self-citationBonacci, T., & Emanuele, M. J. (2025) · Biochemical Society Transactions · doi:10.1042/bst20240859 · Cited by 3
Proteome Analysis of the Ubiquitin Pathway
Peng, J. (2008) · Wiley eBooks · doi:10.1002/9780470369630.ch30 · Cited by 1
Ubiquitination and deubiquitination involved in cell cycle progression
van Leuken, R. J. (2008) · Utrecht University Repository (Utrecht University)
Epstein-Barr virus encoded deconjugases and AmotL2 in control of cell topology
Hildebrand, S. (2014) · Figshare
Villeneuve, N. (2011) · UA Campus Repository (The University of Arizona)
Kapuria, V. (2010) · Digital Commons-TMC (Texas Medical Center)
Chemical and biochemical studies of ubiquitin conjugation machinery
Pandya, R. K. (2010) · DSpace@MIT (Massachusetts Institute of Technology)
Development of Biomolecular Tools for Studying Host-Virus Interactions of the Hepatitis C Virus
Ardekan, N. N. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4753
UCH-L1 in DLBCL: marker or target?
Pagano, J. S., & Shackelford, J. (2016) · Blood · doi:10.1182/blood-2016-01-689984
Claessen, J. H. L., & Witte, M. D. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6439-0_13
Novel activity-based probes for functional analysis of deubiquitinating enzymes
Iphöfer, A. (2012) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-201205021132-0
Dissecting Intracellular Proteolysis Using Small Molecule Inhibitors and Molecular Probes
Ovaa, H., Overkleeft, H. S., Kessler, B. M., & Ploegh, H. L. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch3a
Self-citationWang, Y., Wei, W., Peng, R., Chen, H., Zhou, N., Wu, L., Shi, H., Chen, X., Wang, D., Wei, J., et al. (2022) · Austin Journal of Cancer and Clinical Research · doi:10.26420/austinjcancerclinres.2022.1101
Shahab Uddin, M. S., Ahmed, M., Bavi, P. P., El-Sayed, R., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H. S., Alhomoud, S. J., Al‐Dayel, F., Hussain, A. R., et al. (2023) · doi:10.1158/0008-5472.c.6497727
Shahab Uddin, M. S., Ahmed, M., Bavi, P. P., El-Sayed, R., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H. S., Alhomoud, S. J., Al‐Dayel, F., Hussain, A. R., et al. (2023) · doi:10.1158/0008-5472.c.6497727.v1
Bornkamm, G. W., Kelly, G. L., & Ross, A. M. (2025) · Current topics in microbiology and immunology · doi:10.1007/82_2025_301 · Cited by 2
BindingDB Entry 50007936: Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors.
BindingDB (2021) · UC San Diego · doi:10.7270/q2gf0xtc
BindingDB Entry 50032222: Mechanisms, biology and inhibitors of deubiquitinating enzymes.
BindingDB (2011) · UC San Diego · doi:10.7270/q2kw5g7p
BindingDB (2021) · UC San Diego · doi:10.7270/q23r0xbs
Proteinase Optical Imaging Tools for Cancer Detection and Response to Therapy
McIntyre, J. O., & Matrisian, L. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-93874-5_7
Metadata
- Authors
- Ovaa, H., Kessler, B. M., Rolén, U., Galardy, P. J., Ploegh, H. L., & Masucci, M. G.
- Affiliations
- Harvard University (US)
- Corresponding author
- Masucci, Maria G.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-02-11
- Volume
- 101
- Issue
- 8
- Pages
- 2253-2258
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC356937
- OpenAlex
- W2130935241
- Cited by
- 190
- References
- 49
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 5 · 2019: 11 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 7 · 2014: 13 · 2013: 7 · 2012: 9
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Multiple Myeloma Research Foundation
- Stiftelsen för Strategisk Forskning
- Cancerfonden
- Karolinska Institutet
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- ubiquitin-specific protease, deubiquitination, virus-infected cells, cancer cell lines, Epstein-Barr virus, UCHL1, USP5, USP7, USP13, USP15, USP22, lymphocyte activation, mitogen stimulation, cell proliferation, growth transformation, functional proteomics
- MeSH terms
- Ubiquitin-Specific Peptidase 7, B-Lymphocytes, Cell Line, Humans, Endopeptidases, Mass Spectrometry, T-Lymphocytes, Ubiquitin Thiolesterase, Cell Line, Tumor, Ubiquitin-Specific Proteases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review